-- Announcement on Resolutions of the 19th Meeting of the 5th Board of Directors
Securities code: 603739 Securities abbreviation: Weilan Biotechnology Announcement number: 2025-035 Qingdao Weilan Biotechnology Co., Ltd.
Announcement on the Resolution of the 19th Meeting of the Company’s Fifth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
1. Convening of board of directors meetings
The 19th meeting of the fifth board of directors of Qingdao Weilan Biological Co., Ltd. (hereinafter referred to as the "Company") was held on August 27, 2025 in the company's conference room through a combination of on-site and communication methods. The meeting notice was sent by email on August 17, 2025. 5 directors should be present at this meeting, but 5 were actually present. The meeting was chaired by Mr. Chen Gang, chairman and general manager of the company. The procedures for convening the meeting and the matters to be reviewed complied with relevant regulations such as the Company Law of the People's Republic of China and the Articles of Association of Qingdao Weilan Biological Co., Ltd., and the resolutions formed were legal and valid.
2. Review status of board of directors meeting
- Review and adopt the "Proposal on the Company's 2025 Semi-annual Report and Summary"
For details, please refer to the "2025 Semi-Annual Report of Qingdao Weilan Biotechnology Co., Ltd." and the "Summary of the 2025 Semi-annual Report of Qingdao Weilan Biotechnology Co., Ltd." disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn).
This proposal was reviewed and approved at the 11th meeting of the Audit Committee of the fifth session of the Board of Directors before being submitted to the Board of Directors.
Voting votes: 5 votes, votes in favor: 5 votes, votes against: 0 votes, abstention votes: 0 votes.
- Review and adopt the "Proposal on the Special Report on the Deposit and Actual Use of Funds Raised by the Company in the Half-Year of 2025"
For details, please refer to the "Special Report on the Deposit and Actual Use of Funds Raised by Qingdao Weilan Biotechnology Co., Ltd. for the Half Year of 2025" disclosed by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) (Announcement No.: 2025-037).
Voting votes: 5 votes, votes in favor: 5 votes, votes against: 0 votes, abstention votes: 0 votes.
Announcement is hereby made.
Board of Directors of Qingdao Weilan Biological Co., Ltd.
August 28, 2025